Abstract

A 67-year-old female presented with a history of right breast invasive ductal carcinoma and right axillary metastasis five years ago, status post bilateral mastectomies and right axillary lymph node dissection. Three years ago, she underwent implant reconstruction. She was diagnosed with metastasis to mediastinal lymph nodes one year ago after abnormal PET-CT and bronchoscopy. Fluorodeoxyglucose (FDG) PET-CT was performed for surveillance as she is currently on endocrine therapy. Fluorodeoxyglucose PET-CT demonstrated interval increase in size and hypermetabolic activity of a left axillary lymph node when compared to the prior year (Figure 1). Subsequent targeted left axillary US was performed for biopsy of this lymph node (Figure 2). On the biopsy images, the lymph node demonstrates a well-defined anterior margin with hyperechogenicity and echogenic noise. The differential diagnosis for unilateral lymphadenopathy includes benign and malignant etiologies (1,2). Benign etiologies include reactive...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.